Usefulness of intratumoral perfusion analysis for assessing biological features of non-functional pancreatic neuroendocrine neoplasm

被引:0
作者
Notake, Tsuyoshi [1 ]
Shimizu, Akira [1 ]
Kubota, Koji [1 ]
Sugenoya, Shinsuke [1 ]
Umemura, Kentaro [1 ]
Goto, Takamune [1 ]
Yamada, Akira [2 ]
Fujinaga, Yasunari [2 ]
Soejima, Yuji [1 ]
机构
[1] Shinshu Univ, Sch Med, Dept Surg, Div Gastroenterol Hepatobiliary Pancreat Transplan, Asahi 3-1-1, Matsumoto 3908621, Japan
[2] Shinshu Univ, Sch Med, Dept Radiol, Matsumoto, Japan
关键词
PanNENs; Non-functional; Perfusion analysis; CONTRAST-ENHANCEMENT; MICROVASCULAR DENSITY; ENDOCRINE TUMORS; CT; ANGIOGENESIS; RECURRENCE; EXPRESSION; MANAGEMENT; RESECTION; SURVIVAL;
D O I
10.1007/s00423-023-03219-2
中图分类号
R61 [外科手术学];
学科分类号
摘要
Purpose Here, we evaluated the usefulness of intratumoral perfusion analysis using preoperative contrast-enhanced CT (E-CT) to assess biological features of non-functional pancreatic neuroendocrine neoplasms (NF-PanNENs).Methods We retrospectively studied 44 patients who underwent curative surgery for NF-PanNENs. We used preoperative E-CT with compartment model analysis to calculate the tumor perfusion parameters K1 (inflow rate constant), 1/k2 (mean transit time), and K1/k2 (distribution volume). We assessed the association between perfusion parameters and biological features of NF-PanNENs, including the WHO classification tumor histopathological grade and prognosis after surgery.Results Patients in this study had a neuroendocrine tumor (NET) G1 (n = 32) or NET G2 (n = 12). Neither NET G3 or NEC tumors were observed. Among perfusion parameters, K1 was the most accurate predictor of the high-grade tumor (AUC: 0.726). K1-low (< 0.028 s(-1)) was significantly associated with large tumors (>= 20 mm) (p = 0.022), high mitotic index (p = 0.017), high Ki-67 index (p = 0.004), and lymphatic invasion (p = 0.025). Synchronous extra-pancreatic metastasis, including lymph node metastasis or liver metastasis, more frequently developed in K1-low patients than in K1-high patients (29% vs 4%, p = 0.025). Disease-free survival of patients with a K1-low tumor was poorer than that of patients with a K1-high tumor (p = 0.005). Furthermore, no patient with a K1-high tumor developed recurrence after initial surgery.Conclusion The perfusion parameters obtained using E-CT were significantly associated with biological features and prognosis of NF-PanNENs.
引用
收藏
页数:9
相关论文
共 33 条
[1]   Contrast-enhancement ratio on multiphase enhanced computed tomography predicts recurrence of pancreatic neuroendocrine tumor after curative resection [J].
Arai, Takuma ;
Kobayashi, Akira ;
Fujinaga, Yasunari ;
Yokoyama, Takahide ;
Shimizu, Akira ;
Motoyama, Hiroaki ;
Kitagawa, Noriyuki ;
Notake, Tsuyoshi ;
Shirota, Tomoki ;
Fukushima, Kentaro ;
Masuo, Hitoshi ;
Kadoya, Masumi ;
Miyagawa, Shin-ichi .
PANCREATOLOGY, 2016, 16 (03) :397-402
[2]   Peak contrast enhancement in CT and MR angiography: When does it occur and why? Pharmacokinetic study in a porcine model [J].
Bae, KT .
RADIOLOGY, 2003, 227 (03) :809-816
[3]   Preoperative assessment of microvessel density in nonfunctioning pancreatic neuroendocrine tumors (NF-PanNETs) [J].
Battistella, Anna ;
Partelli, Stefano ;
Andreasi, Valentina ;
Marinoni, Ilaria ;
Palumbo, Diego ;
Tacelli, Matteo ;
Lena, Marco Schiavo ;
Muffatti, Francesca ;
Mushtaq, Junaid ;
Capurso, Gabriele ;
Arcidiacono, Paolo Giorgio ;
De Cobelli, Francesco ;
Doglioni, Claudio ;
Perren, Aurel ;
Falconi, Massimo .
SURGERY, 2022, 172 (04) :1236-1244
[4]   Microvascular density and hypoxia-inducible factor pathway in pancreatic endocrine tumours: negative correlation of microvascular density and VEGF expression with tumour progression [J].
Couvelard, A ;
O'Toole, D ;
Turley, H ;
Leek, R ;
Sauvanet, A ;
Degott, C ;
Ruszniewski, P ;
Belghiti, J ;
Harris, AL ;
Gatter, K ;
Pezzella, F .
BRITISH JOURNAL OF CANCER, 2005, 92 (01) :94-101
[5]   Pancreatic Endocrine Tumors: Tumor Blood Flow Assessed with Perfusion CT Reflects Angiogenesis and Correlates with Prognostic Factors [J].
d'Assignies, Gaspard ;
Couvelard, Anne ;
Bahrami, Stephane ;
Vullierme, Marie-Pierre ;
Hammel, Pascal ;
Hentic, Olivia ;
Sauvanet, Alain ;
Bedossa, Pierre ;
Ruszniewski, Philippe ;
Vilgrain, Valerie .
RADIOLOGY, 2009, 250 (02) :407-416
[6]   Trends in the Incidence, Prevalence, and Survival Outcomes in Patients With Neuroendocrine Tumors in the United States [J].
Dasari, Arvind ;
Shen, Chan ;
Halperin, Daniel ;
Zhao, Bo ;
Zhou, Shouhao ;
Xu, Ying ;
Shih, Tina ;
Yao, James C. .
JAMA ONCOLOGY, 2017, 3 (10) :1335-1342
[7]   ENETS Consensus Guidelines Update for the Management of Patients with Functional Pancreatic Neuroendocrine Tumors and Non-Functional Pancreatic Neuroendocrine Tumors [J].
Falconi, M. ;
Eriksson, B. ;
Kaltsas, G. ;
Bartsch, D. K. ;
Capdevila, J. ;
Caplin, M. ;
Kos-Kudla, B. ;
Kwekkeboom, D. ;
Rindi, G. ;
Kloeppel, G. ;
Reed, N. ;
Kianmanesh, R. ;
Jensen, R. T. .
NEUROENDOCRINOLOGY, 2016, 103 (02) :153-171
[8]  
Gill AJ., 2019, WHO Classification of Tumours, V1, P343
[9]   Impact of Extent of Surgery on Survival in Patients with Small Nonfunctional Pancreatic Neuroendocrine Tumors in the United States [J].
Gratian, Lauren ;
Pura, John ;
Dinan, Michaela ;
Roman, Sanziana ;
Reed, Shelby ;
Sosa, Julie Ann .
ANNALS OF SURGICAL ONCOLOGY, 2014, 21 (11) :3515-3521
[10]   Pancreatic neuroendocrine tumors (PNETs): incidence, prognosis and recent trend toward improved survival [J].
Halfdanarson, T. R. ;
Rabe, K. G. ;
Rubin, J. ;
Petersen, G. M. .
ANNALS OF ONCOLOGY, 2008, 19 (10) :1727-1733